Cargando…
Conversion surgery for microsatellite instability-high gastric cancer with a complete pathological response to pembrolizumab: a case report
BACKGROUND: Immune checkpoint inhibitors are reportedly effective in treating microsatellite instability (MSI)-high gastric cancer. There are a few case reports of conversion surgery (CS) with nivolumab but none with pembrolizumab. Herein, we describe a patient with MSI-high gastric cancer who was s...
Autores principales: | Hidaka, Yoshifumi, Arigami, Takaaki, Osako, Yusaku, Desaki, Ryosuke, Hamanoue, Masahiro, Takao, Sonshin, Kirishima, Mari, Ohtsuka, Takao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9185925/ https://www.ncbi.nlm.nih.gov/pubmed/35689267 http://dx.doi.org/10.1186/s12957-022-02661-8 |
Ejemplares similares
-
Conversion surgery for hepatocellular carcinoma with portal vein tumor thrombus after successful atezolizumab plus bevacizumab therapy: a case report
por: Hidaka, Yoshifumi, et al.
Publicado: (2022) -
Successful conversion surgery for stage IV gastric cancer with liver metastases after second-line chemotherapy with ramucirumab and paclitaxel: a case report
por: Fukuda, Kosuke, et al.
Publicado: (2022) -
Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report
por: Matsumoto, Ryu, et al.
Publicado: (2020) -
Successful pembrolizumab treatment of microsatellite instability‐high intrahepatic cholangiocarcinoma: A case report
por: Ikeda, Yuki, et al.
Publicado: (2021) -
Durable response to pembrolizumab in microsatellite instability‐high advanced adrenocortical carcinoma
por: Senda, Masaya, et al.
Publicado: (2023)